Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-09-03
2009-06-09
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S292000
Reexamination Certificate
active
07544691
ABSTRACT:
The invention relates to the guanine derivatives of general formula (I), and to hydrates or solvents thereof, for use as neuropeptide FF receptor antagonists in the treatment of pains and hyperalgesia, of withdrawal symptoms of addiction to alcohol, psychotropic drugs or nicotine and in the prevention of or recovery from these addictions, for the regulation of insulin release, food intake, memory functions, blood pressure, electrolyte and energy metabolism, and in the treatment of urinary incontinence
REFERENCES:
patent: 3505327 (1970-04-01), Miller et al.
patent: 4880932 (1989-11-01), Moriya et al.
patent: 2003/0139431 (2003-07-01), Kawakami et al.
patent: 22 06 385 (1972-02-01), None
patent: 2 206 385 (1973-08-01), None
patent: WO-03/026667 (2003-04-01), None
patent: WO 03/026667 (2003-07-01), None
Baldwin, John E. et al; “Quantitative Analyses of the Seven Isomeric 3,4- and 3,6-Dimethylcyclohexenes by Gas Chromatography”; J. Org. Chem. vol. 65, No. 21, 2000, pp. 7145-7150.
Hajos, Gyorgy et al.; “Synthesis and Chiroptical Properties of 5α-Cholest-2-Eno[2,3-b]Pyrazine Derivatives”; Heterocycles, vol. 28, No. 2, 1989, pp. 783-789.
Kaiho, Tatsuo et al.; “Cardiotonic Agents. 1-Methyul-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinones and Related Compounds. Synthesis and Activity1”; Journal of Medicinal Chemistry, 1989, vol. 32, No. 2, pp. 351-357.
Meth-Cohn, Otto et al; “A Versatile New Synthesis of Quinolines and Related Fused Pyridines. Part 12.1 A General Synthesis of 2-Chloropyridines and 2-Pyridones”; J. Chem. Soc. Perkin Trans. I (1984), pp. 1173-1182.
Panula, Pertti et al; “Neuropeptide FF, A Mammalian Neuropeptide With Multiple Functions”; Progress in Neurobiology vol. 48 (1996), pp. 461-487.
Roumy, Michel et al.; “Neuropeptide FF, pain and analgesia”; European Journal of Pharmacology 345 (1998), pp. 1-11.
Secor, Henry et al; “Synthesis and Screening of Some Trifluoromethyl Pyrazoles”; Journal of Medicinal Chemistry, 1971, vol. 14, No. 10, pp. 997-998.
Sontjens, Serge et al; “A Multiple Hydrogen-Bond Scaffold Based on Dipyrimidin-2-ylamine”; Organic Letters 2001, vol. 3, No. 24, pp. 3887-3889.
Thesing and Muller; Uber Eine Neue Methode Zur Darstellung Vonα-Pyridonen Und Die Synthese Des Nicotellins; Chem. Ber. (1957), 90, pp. 711-723.
Vijn, Robert J. et al; “Synthesis of 6-Substituted 2-(N-Acetylamino)pyridines and 2-Aminopyridines by Cyclization of 5-Oximinoalkanenitriles”; J. Org. Chem., vol. 58, No. 4, 1993, pp. 887-891.
Yokoo, Akira et al; “Studies on Seven-membered Heterocyclic Compounds Containing Nitrogen. I. Synthesis of 1-Azacycloheptan-4 one Hydrochloride”; Bull. Chem. Soc. Japan (Jul. 1956), vol. 29, No. 5, pp. 631-632.
Lefrere et al.; “Neuropeptide AF and FF Modulation of Adipocyte Metabolism”; The Journal of Biological Chemistry, vol. 277, No. 42, Issue of Oct. 18, 2002, pp. 39169-39178.
Breu Volker
Fecher Anja
Fretz Heinz
Giller Thomas
Hilpert Kurt
Actelion Pharmaceuticals Ltd.
Hunton & Williams LLP
McDowell Brian
Wilson James O
LandOfFree
Guanidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4119569